Dr. Klaus Frueh is the Co-Founder & Scientific Advisor at Vir Biotechnology Inc.
As the Co-Founder & Scientific Advisor of Vir Biotechnology Inc, the total compensation of Dr Frueh at Vir Biotechnology Inc is 177,661$. There are 15 executives at Vir Biotechnology Inc getting paid more, with George Scangos having the highest compensation of 3,944,610$.
Dr Frueh is 60, he's been the Co-Founder & Scientific Advisor of Vir Biotechnology Inc since . There are 12 older and 11 younger executives at Vir Biotechnology Inc. The oldest executive at Vir Biotechnology Inc is Phillip Sharp, 75, who is the Independent Director.
Klaus's mailing address filed with the SEC is C/O VIR BIOTECHNOLOGY, INC., 499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, 94158.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over 197,171,926$ worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth 139,246,875$ . The most active insiders traders include Norbert W Bischofberger、Endurance (Cayman) Ltd Sb I...、Kristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of 478,115$. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth 95,082$.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: